Louise M Gresham, B.Sc.H., Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada, Roxana M Barbu, M.Cog., Institute of Cognitive Science, Carleton University, Ottawa, ON, Canada, Jason A Berard, B.Sc.H., Psychology, University of Ottawa, Ottawa, ON, Canada and Lisa A.S. Walker, PhD, C.Psych., Psychology, The Ottawa Hospital, Ottawa, ON, Canada

Lucille J. Carriere, Ph.D.1, Amy B. Sullivan, Psy.D.2 and Lael A. Stone, M.D.2, (1)Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Murfreesboro, TN, (2)Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH

Maha Abu-AlHawa, B.Sc.H., Institute of Cognitive Science, Carleton University, Ottawa, ON, Canada, Jason A Berard, B.Sc.H., Psychology, University of Ottawa, Ottawa, ON, Canada, Leila Osman, BA., Ottawa Hospital Research Institute, Ottawa, ON, Canada, Louise M Gresham, B.Sc.H., Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada and Lisa A.S. Walker, PhD, C.Psych., Psychology, The Ottawa Hospital, Ottawa, ON, Canada

Eliot Lopez, Ph.D., Lara Stepleman, Ph.D. and Rebecca M. Floyd, Ph.D., Georgia Regents University, Augusta, GA

Rita M Carroll, Ph.D., CPCRT and Mark B Cola, B.A., CBIS, Main Line Rehabilitation Associates, Exton, PA

Serkan Ozakbas, Professor Of Neurology1, Bilge Piri Cinar, MD2, Gorkem Kosehasanogullari, MD3 and Pinar Yigit, Psycologist1, (1)Department of Neurology, Dokuz Eylul University, Izmir, Turkey, (2)Giresun State Hospital, Giresun, Turkey, (3)Usak State Hospital, Usak, Turkey

Silvana L Costa, PhD1,2, John DeLuca, Ph.D.1,2 and Nancy D Chiaravalloti, PhD1,2, (1)School of Medicine, Rutgers University, Newark, NJ, (2)Neuropsychology and Neuroscience Research, Kessler Foundation, West Orange, NJ

Thomas R Valentine, BS1, Brittney Schirda, MA1, Jacqueline A Nicholas, MD, MPH2 and Ruchika Prakash, PhD1, (1)Department of Psychology, The Ohio State University, Columbus, OH, (2)OhioHealth Multiple Sclerosis Center, Columbus, OH

Anna Kazimirchik, RN MSCN, Fraser Health Multiple Sclerosis Clinic, Burnaby, BC, Canada

Erika Mitchell, FNP-C and Faria Amjad, MD, Neurology, MedStar Georgetown University Hospital, Washington, DC

Helena Bulka, DO, Suzanne Croll, BSc, Stanton Elias, MD and Mirela Cerghet, MD, PhD, Neurology, Henry Ford Hospital, Detroit, MI

Jay H Rosenberg, MD, Staff Physician MS Center of Southern CA, Carlsbad, CA and Michael Zorniak, Ph.D., MSL at Teva Pharmaceuticals, San Diego, CA

Joseph J Sabatino Jr., MD/PhD, Neurology, Johns Hopkins Hospital, Baltimore, MD and Scott D Newsome, D.O., Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD

Joshua D Katz, M.D.1, Ellen S Lathi, M.D.1, Lauren M Heyda, B.S.1 and David Titelbaum, M.D.2, (1)The Elliot Lewis Center for Multiple Sclerosis Care, Brighton, MA, (2)Shields MRI, Brockton, MA

Kathryn B Holroyd, BA1, Kathryn Fitzgerald, ScD2, Scott D Newsome, D.O.3, Shiv Saidha, MD4, Peter A Calabresi, MD4 and Ellen Mowry, MD, MCR5, (1)School of Medicine, Johns Hopkins, Baltimore, MD, (2)Neurology, Johns Hopkins Hospital, Baltimore, MD, (3)Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, (4)Neurology, Johns Hopkins University, Baltimore, MD, (5)Neurology, Johns Hopkins School of Medicine, Baltimore, MD

Weredeselam M Olango, MD, Larysa Gromko, MD, Michael Jaker, MD and Machteld Hillen, MD, Neurology, Rutgers NJMS, Newarks, NJ

Weredeselam M Olango, MD and Machteld Hillen, MD, Neurology, Rutgers NJMS, Newarks, NJ

Aaron E Miller, MD1, Jiwon Oh, MD2, Karthinathan Thangavelu, PhD3, Philippe Truffinet, MD4, Steve Cavalier, MD3 and David Rog, MD5, (1)Icahn School of Medicine at Mount Sinai, New York, NY, (2)St. Michael’s Hospital, Toronto, ON, Canada, (3)Genzyme, a Sanofi company, Cambridge, MA, (4)Genzyme, a Sanofi company, Chilly-Mazarin, France, (5)Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom of Great Britain and Northern Ireland

Aaron E Miller, MD1, Ludwig Kappos, MD2, Jiwon Oh, MD3, Karthinathan Thangavelu, PhD4, Pascal Rufi, MD5, Steve Cavalier, MD4, Philippe Truffinet, MD5 and Giancarlo Comi, MD6, (1)Icahn School of Medicine at Mount Sinai, New York, NY, (2)University Hospital Basel, Basel, Switzerland, (3)St. Michael’s Hospital, Toronto, ON, Canada, (4)Genzyme, a Sanofi company, Cambridge, MA, (5)Genzyme, a Sanofi company, Chilly-Mazarin, France, (6)University Vita-Salute San Raffaele, Milan, Italy

Amal Fuad Almahroos, BSc, Zahra Almosawi, BSc, Hawra Alalwan, BSc, Reem Abdulla, Bsc, Fajer Alammadi, BSc, Ahmed Al-Mahrezi, BSc, Ahmmed Almubarak, BSc, Ayman Mohamed, BSc and Amer Kamal, Professor, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain

Amit Bar-Or, MD, FRCPC1, Douglas L Arnold, MD1,2, Giancarlo Comi, MD3, Hans-Peter Hartung, MD, FRCP, FAAN, FANA4, Stephen L Hauser, MD5, Fred Lublin, MD6, Krzysztof Selmaj, MD, PhD7, Anthony Traboulsee, MD, FRCPC8, Peter Chin, MD9, Paulo Fontoura, MD, PhD10, Hideki Garren, MD, PhD10, Gaelle Klingelschmitt, MSc10, Donna Masterman, MD9 and Ludwig Kappos, MD, PhD11, (1)McGill University, Montreal, QC, Canada, (2)NeuroRx Research, Montreal, QC, Canada, (3)University Vita-Salute San Raffaele, Milan, Italy, (4)Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany, (5)University of California, San Francisco, CA, (6)Icahn School of Medicine at Mount Sinai, New York, NY, (7)Medical University of Lodz, Lodz, Poland, (8)University of British Columbia, Vancouver, BC, Canada, (9)Genentech, Inc., South San Francisco, CA, (10)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (11)University Hospital Basel, Basel, Switzerland

Chris M Kozma, PhD1, Frederick Munschauer, MD2 and Amy L Phillips, PharmD2, (1)CK Consulting Associates, LLC, Saint Helena Island, SC, (2)EMD Serono, Inc., Rockland, MA

Chris M Kozma, PhD1, Frederick Munschauer, MD2 and Amy L Phillips, PharmD2, (1)CK Consulting Associates, LLC, Saint Helena Island, SC, (2)EMD Serono, Inc., Rockland, MA

Jacqueline Nicholas, MD, MPH1, Aaron Boster, MD2, Wei-Shi Yeh, PhD3, Robert Garland, MS3, Monica A Fay, PharmD4, Ravi Iyer, PhD3 and Andrew Lee, PhD3, (1)Health Economics & Outcomes Research, Novartis Pharmaceutical Corporation, East Hanover, NJ, (2)OhioHealth Neurological Physicians, Columbus, OH, (3)Global Health Economics and Outcomes Research, Biogen, Cambridge, MA, (4)US Medical Affairs, Biogen, Weston, MA

Anthony Traboulsee, MD, FRCPC1, Regina Berkovich, MD, PhD2, Hao Zhang, PhD3, Fernando Dangond, MD, FAAN, MBA4 and David Li, MD1, (1)University of British Columbia, Vancouver, BC, Canada, (2)University of Southern California, Los Angeles, CA, (3)EMD Serono, Inc., Rockland, MA, (4)EMD Serono, Inc., Billerica, MA

Barry A Singer, MD1, Stephen Krieger, MD2, Regina Berkovich, MD3, Mark S Freedman, MD4, David H Margolin, MD, PhD5, Karthinathan Thangavelu, PhD5 and Aaron Boster, MD6, (1)The MS Center for Innovations in Care, Missouri Baptist Medical Center, St Louis, MO, (2)Icahn School of Medicine, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY, (3)Keck School of Medicine, University of Southern California, Los Angeles, CA, (4)University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada, (5)Genzyme, a Sanofi company, Cambridge, MA, (6)OhioHealth Neurological Physicians, Columbus, OH

Bing Zhu, MD, PhD1, Karin Galil, MD, MPH1, Ivan Nestorov, PhD1, Guolin Zhao, PhD1, Venkata Meka, MD1, Jeanelle Kam, MD, CPI2 and Sarah I. Sheikh, MD1, (1)Biogen, Cambridge, MA, (2)Covance Clinical Research Unit, Dallas, TX

Carrie M Hersh, DO, MS1, Samuel Cohn, MD2, Claire Hara-Cleaver, CNP3, Robert Bermel, MD3, Robert J Fox, MD, FAAN3, Jeffrey A Cohen, MD3 and Daniel Ontaneda, MD3, (1)Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV, (2)Cleveland Clinic, Cleveland, OH, (3)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH

Carrie L Sammarco, DNP, FNP-C, MSCN1, Lana Zhovtis Ryerson, MD2 and Lisa Laing, BSN, RN, MSCN1, (1)MS Comprehensive Care Center, NYU Langone, New York, NY, (2)New York State Multiple Sclerosis Consortium, Buffalo, NY

Cecilie Fjeldstad, PhD, Tania Reyna, MD, Jennifer Smith, PA, Tony Sharp, PA and Gabriel Pardo, MD, MS Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK

Christopher M Perrone, MD and Eric Williamson, MD, Neurology, University of Pennsylvania, Philadelphia, PA

Daniel Hewes, B.S.1, Adam Kruszewski, B.S.1, Dallas Boodhoo, B.S.1, Alexandru Tatomir, M.D.1, Vinh Nguyen, D.D.S.2, Gautam K Rao, B.S.1, Walter Royal III, M.D.3, Christopher T Bever Jr., M.D., M.B.A.1, Violeta Rus, M.D., Ph.D2 and Horea Rus, M.D., Ph.D.3, (1)Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, (2)Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, MD, (3)Veterans Administration Multiple Sclerosis Center of Excellence, Baltimore, MD

Daniel Pelletier, MD1, Gavin Giovannoni, MBBCh, PhD2, Douglas L Arnold, MD3,4, Sven Schippling, MD5, David H Margolin, MD, PhD6, Karthinathan Thangavelu, PhD6 and Anthony Traboulsee, MD, FRCPC7, (1)University of Southern California, Los Angeles, CA, (2)Queen Mary University London, Barts and The London School of Medicine, London, United Kingdom, (3)McGill University, Montreal, QC, Canada, (4)NeuroRx Research, Montreal, QC, Canada, (5)University Hospital Zurich and University of Zurich, Zurich, Switzerland, (6)Genzyme, a Sanofi company, Cambridge, MA, (7)University of British Columbia, Vancouver, BC, Canada

Daniel Wynn, MD1, Chris Laganke, MD2, Lesley Schofield, PhD3, Xiangyi Meng, PhD3 and Nadia Tenenbaum, MD3, (1)Consultants in Neurology MS Center, Northbrook, IL, (2)North Central Neurology Associates, Cullman, AL, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ

David Li, MD, FRCPC1, Anthony Traboulsee, MD, FRCPC1, Eric Williamson, MD2, Hao Zhang, PhD3 and Fernando Dangond, MD, FAAN, MBA4, (1)University of British Columbia, Vancouver, BC, Canada, (2)University of Pennsylvania, Philadelphia, PA, (3)EMD Serono, Inc., Rockland, MA, (4)EMD Serono, Inc., Billerica, MA

Demetrios Skias, MD, Neurology, Jesse Brown VA Medical Center, Chicago, IL; Neurology and Rehabilitation, University of Illinois-Chicago, Chicago, IL

Eduardo R Estades, MD1,2, Angel Chinea, MD3, Yatzka G Hernandez Silvestrini, MD2, Ivonne Vicente, MD3, Cristina Rubi, BS3 and Kenneth Stein, MD3,4, (1)Internal Medicine, Christiana Care Health System, Newark, DE, (2)Research/Clinic, San Juan MS Center, Guaynabo, PR, (3)San Juan Multiple Sclerosis Center, Guaynabo, PR, (4)Neuroradiology, San Juan MRI, San Juan, PR

Edward J. Fox, MD, PhD1, Hans-Peter Hartung, MD, FRCP, FAAN, FANA2, Eva Havrdova, MD, PhD3, Brian Steingo, MD4, David H Margolin, MD, PhD5, Karthinathan Thangavelu, PhD5 and Gavin Giovannoni, MBBCh, PhD6, (1)Central Texas Neurology Consultants, Round Rock, TX, (2)Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany, (3)Department of Neurology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, (4)Fort Lauderdale Multiple Sclerosis Center, Pompano Beach, FL, (5)Genzyme, a Sanofi company, Cambridge, MA, (6)Queen Mary University London, Barts and The London School of Medicine, London, United Kingdom

Edward J Fox, MD, Central Texas Neurology Consultants, Round Rock, TX, Gilles Edan, MD, CHU Hopital Pontchaillou, Rennes, France, Mark S Freedman, MD, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada, Xavier Montalban, MD, PhD, Hospital Universitari Vall d’Hebron, Barcelona, Spain, Hans-Peter Hartung, MD, FRCP, FAAN, FANA, Department of Neurology, Heinrich-Heine Universität, Düsseldorf, Germany, Bernhard Hemmer, MD, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Technische Universität München, Munich, Germany, Frederik Barkhof, MD, PhD, VU University Medical Center, Amsterdam, Netherlands, Sven Schippling, MD, University Hospital Zurich, Zurich, Switzerland, Frederick W Foley, Ph.D., School of Psychology, Yeshiva University, New York, NY, Iris-Katharina Penner, PD, COGITO Center for Applied Neurocognition and Neuropsychological Research, Düsseldorf, Germany, Ralf Koelbach, MSc, PAREXEL International, Berlin, Germany, Dirk Pleimes, MD, Myelo Therapeutics GmbH, Berlin, Germany, Gustavo Suarez, MD, Bayer HealthCare Pharmaceuticals, Whippany, NJ, Eva-Maria Wicklein, MD, Bayer Pharma AG, Berlin, Germany and Ludwig Kappos, MD, PhD, Neurology, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital Basel, Basel, Switzerland

Erin E Longbrake, MD, PhD1, Anne H Cross, MD1 and Amber Salter, PhD2, (1)Neurology, Washington University School of Medicine, St Louis, MO, (2)Biostatistics, Washington University in St. Louis, St. Louis, MO